Trial intelligence / Profile preview

PAC-14028 Cream in Rosacea Patients

NCT02583009Phase 2Completed

Sponsor
Amorepacific Corporation
Start
Oct 2014
Primary completion
Aug 2016
Modality
Small Molecules, Drug Delivery Systems
Countries
1
01

Overview

A Phase 2 trial of asivatrep in rosacea, sponsored by Amorepacific Corporation. Started Oct 2014; status: completed.

02

Drugs

asivatrep
03

Conditions

rosacea

Beyond the preview

Go deeper on NCT02583009.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02583009.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call